Purpose
To assess the uridine diphosphate (UDP)-glucuronosyltransferase (UGT) isozymes involved in the glucuronidation of niflumic acid in human liver.
Methods
The glucuronidation activity of niflumic acid was determined in liver microsomes and recombinant UGT isozymes by incubation of niflumic acid with UDP-glucuronic acid (UDPGA).
Results
Incubation of niflumic acid with liver microsomes and UDPGA produced one peak, which was identified as a glucuronide from mass spectrometric analysis. A study involving a panel of recombinant human UGT isozymes showed that glucuronidation activity was highest in UGT1A1 among the isozymes investigated. The glucuronidation in human liver microsomes (HLMs) followed Michaelis-Menten kinetics with a Km value of 16 μM, which is similar to that found with recombinant UGT1A1. The glucuronidation activity of niflumic acid in microsomes from eight human livers significantly correlated with UGT1A1-catalyzed estradiol 3β-glucuronidation activity (r=0.78, p<0.05). β-Estradiol inhibited niflumic acid glucuronidation with an IC50 of 25 μM in HLMs, comparable to that for UGT1A1.
Conclusions
These findings indicate that UGT1A1 is the main isozyme involved in the glucuronidation of niflumic acid in the human liver.
Similar content being viewed by others
References
V. Rejholec (1976) ArticleTitleThe long term treatment of rheumatoid arthritis with niflumic acid or indometazin in double blind controlled trial Med. Klin. 71 1188–1191 Occurrence Handle822265 Occurrence Handle1:STN:280:CSmB28npsVI%3D
G. Houin D. Tremblay F. Bree A. Dufour P. Ledudal J. P. Tillement (1983) ArticleTitleThe pharmacokinetics and availability of niflumic acid in humans Int. J. Clin. Pharmacol. 21 130–134 Occurrence Handle1:CAS:528:DyaL3sXktFSktb4%3D
S. J. Lan T. J. Chando I. Weliky E. C. Schreiber (1973) ArticleTitleMetabolism of niflumic acid-14C: absorption, excretion, and biotransformation by human and dog J. Pharmacol. Exp. Ther. 186 323–330 Occurrence Handle4719785 Occurrence Handle1:CAS:528:DyaE3sXltVSgurg%3D
Y. Mano T. Usui H. Kamimura (2005) ArticleTitleIn vitro inhibitory effects of non-steroidal anti–inflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3β-glucuronidation in human liver microsomes Biopharm. Drug. Dispos. 26 35–39 Occurrence Handle15593333 Occurrence Handle1:CAS:528:DC%2BD2MXpsFamuw%3D%3D Occurrence Handle10.1002/bdd.430
Y. Mano, T. Usui, and H. Kamimura. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9-potent inhibition by niflumic acid-. Biopharm. Drug. Dispos. 27:1–6 (2006).
M. Vietri A. Pietrabissa F. Mosca G. M. Pacifici (2000) ArticleTitleMycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney Eur. J. Clin. Pharmacol. 56 659–664 Occurrence Handle11214772 Occurrence Handle1:CAS:528:DC%2BD3MXlt1Kguw%3D%3D Occurrence Handle10.1007/s002280000227
M. Vietri A. Pietrabissa F. Mosca G. M. Pacifici (2002) ArticleTitleInhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomes Eur. J. Clin. Pharmacol. 58 93–97 Occurrence Handle12012139 Occurrence Handle1:CAS:528:DC%2BD38XjsVWit7Y%3D Occurrence Handle10.1007/s00228-001-0407-4
H. Girard M. H. Court O. Bernard L. C. Fortier L. Villeneuve Q. Hao D. J. Greenblatt L. L. Moltke Particlevon L. Perussed C. Guillemette (2004) ArticleTitleIdentification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver Pharmacogenetics 14 501–515 Occurrence Handle15284532 Occurrence Handle1:CAS:528:DC%2BD2cXmtVGgtbw%3D Occurrence Handle10.1097/01.fpc.0000114754.08559.27
K. Sakaguchi M. Green N. Stock T. S. Reger J. Zunic C. King (2004) ArticleTitleGlucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms Arch. Biochem. Biophys. 424 219–225 Occurrence Handle15047194 Occurrence Handle1:CAS:528:DC%2BD2cXisVejtbs%3D Occurrence Handle10.1016/j.abb.2004.02.004
Y. Mano T. Usui H. Kamimura (2004) ArticleTitleEffect of β-estradiol and propofol on the 4-methylumbeliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9 Biopharm. Drug Dispos. 25 339–344 Occurrence Handle15378558 Occurrence Handle1:CAS:528:DC%2BD2cXhtVWiu77K Occurrence Handle10.1002/bdd.418
R. H. Tukey C. P. Strassburg (2000) ArticleTitleHuman UDP-glucuronosyltransferases: metabolism, expression, and disease Annu. Rev. Pharmacol. Toxicol. 40 581–616 Occurrence Handle10836148 Occurrence Handle1:CAS:528:DC%2BD3cXjs1yht7k%3D Occurrence Handle10.1146/annurev.pharmtox.40.1.581
Y. Watanabe M. Nakajima T. Yokoi (2002) ArticleTitleTroglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10 Drug Metab. Dispos. 30 1462–1469 Occurrence Handle12433820 Occurrence Handle1:CAS:528:DC%2BD38XptVyisb8%3D Occurrence Handle10.1124/dmd.30.12.1462
A. G. Staines P. Sindelar M. W. Coughtrie B. Burchell (2004) ArticleTitleFarnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1 Biochem. J. 384 637–645 Occurrence Handle15320866 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGku7zJ Occurrence Handle10.1042/BJ20040997
G. E. Kuehl J. W. Lampe J. D. Potter J. Bigler (2005) ArticleTitleGlucuronidation of nonsteroidal anti-inflammatory drugs (NSAIDs): identifying the enzymes responsible in human liver microsomes Drug Metab. Dispos. 33 1027–1035 Occurrence Handle15843492 Occurrence Handle1:CAS:528:DC%2BD2MXlslWqsLk%3D Occurrence Handle10.1124/dmd.104.002527
V. Uchaipichat P. I. Mackenzie X. H. Guo D. Gardner-Stephen A. Galetin J. B. Houston J. O. Miners (2004) ArticleTitleHuman UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid Drug Metab. Dispos. 32 413–423 Occurrence Handle15039294 Occurrence Handle1:CAS:528:DC%2BD2cXis1ehtbc%3D Occurrence Handle10.1124/dmd.32.4.413
A. N. Stone P. I. Mackenzie A. Galetin J. B. Houston J. O. Miners (2003) ArticleTitleIsoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7 Drug Metab. Dispos. 31 1086–1089 Occurrence Handle12920162 Occurrence Handle1:CAS:528:DC%2BD3sXmslKluro%3D Occurrence Handle10.1124/dmd.31.9.1086
Y. Ishii S. Takeda H. Yamada K. Oguri (2005) ArticleTitleFunctional protein–protein interaction of drug metabolizing enzymes Front. Biosci. 10 887–895 Occurrence Handle15569627 Occurrence Handle1:CAS:528:DC%2BD2MXis1Snurw%3D
Acknowledgment
We wish to express our gratitude to Mr. Katsuhiro Suzuki for his valuable contribution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mano, Y., Usui, T. & Kamimura, H. Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver. Pharm Res 23, 1502–1508 (2006). https://doi.org/10.1007/s11095-006-0250-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-0250-5